Health AI lab launches with $500M backing; OpenEvidence raises $250M

Sep 28, 2026 · Issue 9 · 3 sources, 3 articles

Former Genentech, Meta and AWS leaders have launched a health AI lab with $500M in backing. OpenEvidence, dubbed the "ChatGPT for doctors", raised $250M and is quietly moving into drug development.

Who is affected and how

pharmaceuticals

The new, well-capitalized players in drug-development AI may become competitors or partners.

doctor

The business model of clinical decision-support tools is expanding toward drug development.

Sources

• Ex-Genentech, Meta, AWS AI leaders launch health AI lab with $500M backingfierce healthcare · Sep 30, 2026
• Ex-Genentech, Meta, AWS AI leaders launch health AI lab with $500M backing - Fierce Healthcarefiercehealthcare.com · Sep 30, 2026
• ‘ChatGPT for Doctors’ OpenEvidence Raises $250M, Quietly Pivots Into Drug Developmentwowtale · Sep 28, 2026

Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.